Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis

Nian Liu(Guilin Medical University), Cong Peng(Central South University)
Journal for ImmunoTherapy of Cancer
September 1, 2023
Cited by 54


Related Papers